Oxford vaccine may be key weapon against new COVID variants [CBS News]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: CBS News
One of the strongest weapons against COVID-19 variants may be a vaccine the FDA hasn't approved yetBy Charlie D'AgataFebruary 26, 2021 / 11:48 AMCOVID vaccines and concern about variantsCOVID vaccines and concern about variants 05:35LondoncoronavirusEarlier this month, the Organization gave the go ahead for theOxford/AstraZeneca vaccineIn the meantime, buoyed by the fact that their vaccine is relatively easy to update, scientists at Britain's Oxford University are modifying it in a preemptive strike to prevent new coronavirus variants, including the variant first discovered in South Africa, from taking hold."Plug and play"Chief designer Professor Sarah Gilbert told CBS that her team has already been working for months on modifying their vaccine to tackle new variants of the coronavirus and expects to have a new version ready in the fall.The ability to turn on a dime is down to the "plug and play" platform used in the original Oxford vaccine, Gilbert said."You d
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- A University of Oxford researcher is testing a revolutionary vaccine to prevent the onset of lung cancer [Yahoo! Finance]Yahoo! Finance
- A University of Oxford researcher is testing a revolutionary vaccine to prevent the onset of lung cancer [Fortune]Fortune
- ANGLE partners with AstraZeneca in groundbreaking oncology contract [Yahoo! Finance]Yahoo! Finance
- AstraZeneca: What The Market's Missing [Seeking Alpha]Seeking Alpha
- Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca [Seeking Alpha]Seeking Alpha
AZN
Sec Filings
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/8/24 - Form 6-K
- AZN's page on the SEC website